{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:01:39Z","timestamp":1791356499423,"version":"4.3.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1136\/ard.2006.068882","type":"journal-article","created":{"date-parts":[[2007,7,20]],"date-time":"2007-07-20T20:34:01Z","timestamp":1184963641000},"page":"735-740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues"],"prefix":"10.1016","volume":"67","author":[{"given":"J","family":"Monfort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-P","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Garcia-Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Martel-Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2006.068882_bib1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/rheumatology\/32.7.562","article-title":"Production of active oxygen species by isolated human chondrocytes.","volume":"32","author":"Henrotin","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2006.068882_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1063-4584(05)80059-7","article-title":"The effects of matrix compression on proteoglycan metabolism in articular cartilage explants.","volume":"2","author":"Guilak","year":"1994","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2006.068882_bib3","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/1529-0131(200006)43:6<1290::AID-ANR11>3.0.CO;2-R","article-title":"Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level.","volume":"43","author":"Pelletier","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.068882_bib4","doi-asserted-by":"crossref","first-page":"20069","DOI":"10.1074\/jbc.M907604199","article-title":"Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis.","volume":"275","author":"Tiku","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2006.068882_bib5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1063-4584(03)00150-X","article-title":"The role of reactive oxygen species in homeostasis and degradation of cartilage.","volume":"11","author":"Henrotin","year":"2003","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2006.068882_bib6","series-title":"Arthritis & Allied Conditions. A Textbook of Rheumatology","first-page":"2199","article-title":"Etiopathogenesis of osteoarthritis.","author":"Martel-Pelletier","year":"2005"},{"key":"10.1136\/ard.2006.068882_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/s101650300001","article-title":"Subchondral bone sclerosis in osteoarthritis: not just an innocent bystander.","volume":"13","author":"Lajeunesse","year":"2003","journal-title":"Modern Rheumatol"},{"key":"10.1136\/ard.2006.068882_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X","article-title":"Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis.","volume":"41","author":"Hilal","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.068882_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/joca.2002.0528","article-title":"Can altered production of interleukin 1\u00ce\u00b2, interleukin-6, transforming growth factor-\u00ce\u00b2 and prostaglandin E2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients.","volume":"10","author":"Massicotte","year":"2002","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2006.068882_bib10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.joca.2005.07.012","article-title":"Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes.","volume":"13","author":"Sanchez","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2006.068882_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1242\/jcs.97.3.411","article-title":"Modulation of native chondroitin sulphate structure in tissue development and in disease.","volume":"97","author":"Caterson","year":"1990","journal-title":"J Cell Sci"},{"key":"10.1136\/ard.2006.068882_bib12","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/art.1780351110","article-title":"Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid.","volume":"35","author":"Shinmei","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.068882_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1331\/154434506775268616","article-title":"Chondroitin product selection for the glucosamine\/chondroitin arthritis intervention trial.","volume":"46","author":"Barnhill","year":"2006","journal-title":"J Am Pharm Assoc"},{"key":"10.1136\/ard.2006.068882_bib14","first-page":"27","article-title":"Metabolic fate of partially depolymerized chondroitin sulfate administered to the rat.","volume":"17","author":"Conte","year":"1991","journal-title":"Drugs Exp Clin Res"},{"key":"10.1136\/ard.2006.068882_bib15","first-page":"768","article-title":"Metabolic fate of exogenous chondroitin sulfate in man.","volume":"41","author":"Conte","year":"1991","journal-title":"Arzneimittelforschung"},{"key":"10.1136\/ard.2006.068882_bib16","first-page":"918","article-title":"Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate.","volume":"45","author":"Conte","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1136\/ard.2006.068882_bib17","first-page":"319","article-title":"Metabolic fate of exogenous chondroitin sulfate in the experimental animal.","volume":"40","author":"Palmieri","year":"1990","journal-title":"Arzneimittelforschung"},{"key":"10.1136\/ard.2006.068882_bib18","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1053\/joca.2002.0824","article-title":"Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers.","volume":"10","author":"Volpi","year":"2002","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl A","key":"10.1136\/ard.2006.068882_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1063-4584(98)80006-X","article-title":"Anti-inflammatory activity of chondroitin sulfate.","volume":"6","author":"Ronca","year":"1998","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2006.068882_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1067\/mcp.2001.116977","article-title":"Simple approach to predict the maximal effect elicited by a drug when plasma concentrations are not available or are dissociated from the effect, as illustrated with chondroitin sulfate data.","volume":"70","author":"du Souich","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1136\/ard.2006.068882_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T","article-title":"Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology.","volume":"41","author":"Blanco","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.068882_bib22","first-page":"455","article-title":"Apoptotic chondrocyte death in human osteoarthritis.","volume":"27","author":"Kim","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.068882_bib23","first-page":"1005","article-title":"Apoptotic chondrocytes from osteoarthrotic human articular cartilage and abnormal calcification of subchondral bone.","volume":"27","author":"Kouri","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.068882_bib24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/emm.2005.58","article-title":"Alternative therapy of earth elements increases the chondroprotective effects of chondroitin sulfate in mice.","volume":"37","author":"Caraglia","year":"2005","journal-title":"Exp Mol Med"},{"key":"10.1136\/ard.2006.068882_bib25","first-page":"S194","article-title":"Chondroitin sulfate reduces nuclear translocation factor NF-kappaB and does not modify the activation state of activating protein-1 (AP-1) [abstract].","volume":"12","author":"Verg\u00c3\u00a9s","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2006.068882_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/joca.1998.0112","article-title":"Effects of chondroitin sulfate and interleukin-1 beta on human articular chondrocytes cultivated in clusters.","volume":"6","author":"Bassleer","year":"1998","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2006.068882_bib27","first-page":"669","article-title":"Influence of polysulphated polysaccharides and hydrocortisone on the extracellular matrix metabolism of human articular chondrocytes in vitro.","volume":"20","author":"Wang","year":"2002","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl A","key":"10.1136\/ard.2006.068882_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1063-4584(98)80005-8","article-title":"Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbit.","volume":"6","author":"Uebelhart","year":"1998","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2006.068882_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/03008207509152169","article-title":"Stimulation of chondroitin sulfate proteoglycan production by chondrocytes in monolayer.","volume":"3","author":"Schwartz","year":"1975","journal-title":"Connect Tissue Res"},{"key":"10.1136\/ard.2006.068882_bib30","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases.","volume":"274","author":"Nagase","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2006.068882_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s000180050320","article-title":"Structural properties of matrix metalloproteinases.","volume":"55","author":"Bode","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"10.1136\/ard.2006.068882_bib32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1172\/JCI114215","article-title":"Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.","volume":"84","author":"Dean","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2006.068882_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s002960050083","article-title":"Expression of the tissue inhibitor of metalloproteinases (TIMPs) gene family in normal and osteoarthritic joints.","volume":"18","author":"Su","year":"1999","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.2006.068882_bib34","doi-asserted-by":"crossref","first-page":"10261","DOI":"10.1021\/bi00496a016","article-title":"Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin).","volume":"29","author":"Suzuki","year":"1990","journal-title":"Biochemistry"},{"key":"10.1136\/ard.2006.068882_bib35","first-page":"237","article-title":"Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3.","volume":"1","author":"Nagase","year":"1992","journal-title":"Matrix Suppl"},{"key":"10.1136\/ard.2006.068882_bib36","first-page":"71","article-title":"Chondroitin sulfate and hyaluronic acid (500\u2013730 kDa) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes.","volume":"31","author":"Monfort","year":"2005","journal-title":"Drugs Exp Clin Res"},{"key":"10.1136\/ard.2006.068882_bib37","first-page":"593","article-title":"Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis.","volume":"19","author":"Hirose","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.068882_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00286763","article-title":"Neutrophil gelatinase levels in plasma and synovial fluid of patients with rheumatic diseases.","volume":"15","author":"Sopata","year":"1995","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.2006.068882_bib39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C","article-title":"Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.","volume":"44","author":"Tetlow","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.068882_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/153537020523000405","article-title":"Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis.","volume":"230","author":"Chou","year":"2005","journal-title":"Exp Biol Med"},{"key":"10.1136\/ard.2006.068882_bib41","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1172\/JCI118636","article-title":"The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: a role in osteoarthritis.","volume":"97","author":"Reboul","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2006.068882_bib42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.joca.2005.12.005","article-title":"Assorted effects of TGFbeta and chondroitin sulfate on p38 and ERK1\/2 activation levels in human articular chondrocytes stimulated with LPS.","volume":"14","author":"Holzmann","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2006.068882_bib43","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2460\/ajvr.2005.66.1870","article-title":"Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants.","volume":"66","author":"Chan","year":"2005","journal-title":"Am J Vet Res"},{"key":"10.1136\/ard.2006.068882_bib44","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/ard.44.12.817","article-title":"Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies.","volume":"44","author":"Dahl","year":"1985","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.068882_bib45","first-page":"75","article-title":"Influence of sulphated glycosaminoglycans upon proteoglycan metabolism of the synovial lining cells.","volume":"1","author":"Verbruggen","year":"1977","journal-title":"Acta Rhumatol Belg"},{"key":"10.1136\/ard.2006.068882_bib46","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/1529-0131(200012)43:12<2687::AID-ANR8>3.0.CO;2-9","article-title":"The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis.","volume":"43","author":"Myers","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.068882_bib47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI0215528","article-title":"The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis.","volume":"110","author":"McCoy","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2006.068882_bib48","first-page":"2013","article-title":"Osteoarthritic mice exhibit enhanced prostaglandin E2 and unchanged calcitonin gene-related peptide release in a novel isolated knee joint model.","volume":"31","author":"Averbeck","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.068882_bib49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1084\/jem.20051310","article-title":"Prostacyclin-IP signaling and prostaglandin E2-EP2\/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis.","volume":"203","author":"Honda","year":"2006","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2006.068882_bib50","doi-asserted-by":"crossref","first-page":"R355","DOI":"10.1186\/ar1195","article-title":"Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis.","volume":"6","author":"Kojima","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2006.068882_bib51","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/art.20437","article-title":"Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1\/2 and p38 signaling pathways.","volume":"50","author":"Masuko-Hongo","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.068882_bib52","first-page":"887","article-title":"Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes.","volume":"32","author":"Li","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.068882_bib53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.joca.2005.01.003","article-title":"Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants.","volume":"13","author":"Chan","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2006.068882_bib54","first-page":"1329","article-title":"Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate.","volume":"33","author":"Chan","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.068882_bib55","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","article-title":"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.","volume":"354","author":"Clegg","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2006.068882_bib56","first-page":"577","article-title":"Effects of chondroitin sulphate-C on bradykinin-induced proteoglycan depletion in rats.","volume":"49","author":"Omata","year":"2000","journal-title":"Arzneimittelforschung"},{"key":"10.1136\/ard.2006.068882_bib57","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar748","article-title":"Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats.","volume":"5","author":"Campo","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2006.068882_bib58","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/030097498442271","article-title":"Carnitine and antioxidants levels in patients with rheumatoid arthritis.","volume":"27","author":"Kiziltunc","year":"1998","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2006.068882_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jat.736","article-title":"The glutathione defense system in the pathogenesis of rheumatoid arthritis.","volume":"21","author":"Hassan","year":"2001","journal-title":"J Appl Toxicol"},{"key":"10.1136\/ard.2006.068882_bib60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0300-483X(02)00448-1","article-title":"Oxy radicals, lipid peroxidation and DNA damage.","volume":"181\u2013182","author":"Marnett","year":"2002","journal-title":"Toxicology"},{"key":"10.1136\/ard.2006.068882_bib61","first-page":"129","article-title":"The effect of glycosaminoglycans and proteoglycans on lipid peroxidation.","volume":"6","author":"Albertini","year":"2000","journal-title":"Int J Mol Med"},{"key":"10.1136\/ard.2006.068882_bib62","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/10715760410001694017","article-title":"Reduction of DNA fragmentation and hydroxyl radical production by hyaluronic acid and chondroitin-4-sulphate in iron plus ascorbate-induced oxidative stress in fibroblast cultures.","volume":"38","author":"Campo","year":"2004","journal-title":"Free Radic Res"},{"key":"10.1136\/ard.2006.068882_bib63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1248\/bpb.27.47","article-title":"Effects of low molecular weight chondroitin sulfate on type II collagen-induced arthritis in DBA\/1J mice.","volume":"27","author":"Cho","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"10.1136\/ard.2006.068882_bib64","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/ar2325","article-title":"Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study.","volume":"9","author":"Kwan Tat","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2006.068882_bib65","unstructured":"Kwan Tat S, Pelletier JP, Lajeunesse D, Fahmi H, Lavigne M, Martel-Pelletier J,. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor \u00ce\u00baB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clin Exp Rheumatol. In press."},{"key":"10.1136\/ard.2006.068882_bib66","first-page":"1862","article-title":"Anti-arthrosis treatments: efficacy and tolerance of chondroitin sulfates (CS 4&6).","volume":"27","author":"Conrozier","year":"1998","journal-title":"Presse Med"},{"issue":"Suppl A","key":"10.1136\/ard.2006.068882_bib67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1063-4584(98)80011-3","article-title":"Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study.","volume":"6","author":"Uebelhart","year":"1998","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl A","key":"10.1136\/ard.2006.068882_bib68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1063-4584(98)80010-1","article-title":"Chondroitin sulfate: S\/DMOAD (structure\/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA.","volume":"6","author":"Verbruggen","year":"1998","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2006.068882_bib69","first-page":"31","article-title":"Efficacy and tolerability of 800 mg oral chondroitin 4&6 sulfate in the treatment of knee osteoarthritis: a randomised, double-blind, multicentre study versus placebo.","volume":"24","author":"Malaise","year":"1999","journal-title":"Litera Rheumatol"},{"key":"10.1136\/ard.2006.068882_bib70","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.joca.2004.01.004","article-title":"Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo.","volume":"12","author":"Uebelhart","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2006.068882_bib71","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.20867","article-title":"Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial.","volume":"52","author":"Michel","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.068882_bib72","unstructured":"Kahan A,. STOPP (STudy on Osteoarthritis Progression Prevention): a new two-year trial with chondroitin 4&6 sulfate (CS). 2006; http:\/\/www.ibsa.ch\/eular_2006_amsterdam_vignon-2.pdf."},{"key":"10.1136\/ard.2006.068882_bib73","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7326\/0003-4819-146-8-200704170-00009","article-title":"Meta-analysis: chondroitin for osteoarthritis of the knee or hip.","volume":"146","author":"Reichenbach","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2006.068882_bib74","first-page":"75","article-title":"Chondrocyte apoptosis induced by nitric oxide.","volume":"146","author":"Blanco","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.2006.068882_bib75","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/1529-0131(199807)41:7<1266::AID-ART18>3.0.CO;2-Y","article-title":"Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis.","volume":"41","author":"Hashimoto","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.068882_bib76","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.4049\/jimmunol.165.6.3402","article-title":"The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2.","volume":"165","author":"Notoya","year":"2000","journal-title":"J Immunol"},{"key":"10.1136\/ard.2006.068882_bib77","first-page":"2165","article-title":"Nitric oxide-induced cell death in human osteoarthritc synoviocytes is mediated by tyrosine kinase activation and hydrogen peroxide and\/or superoxide formation.","volume":"29","author":"Jovanovic","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.068882_bib78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/bbrc.1995.1003","article-title":"Nitric oxide activates metalloprotease enzymes in articular cartilage.","volume":"206","author":"Murrell","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ard.2006.068882_bib79","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0014-5793(94)00994-5","article-title":"Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture.","volume":"352","author":"Hauselmann","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1136\/ard.2006.068882_bib80","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/bbrc.1994.1426","article-title":"Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1.","volume":"200","author":"Taskiran","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ard.2006.068882_bib81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1063-4584(96)80009-4","article-title":"The increased synthesis of inducible nitric oxide inhibits IL-1Ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation.","volume":"4","author":"Pelletier","year":"1996","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2006.068882_bib82","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI119280","article-title":"Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide.","volume":"99","author":"Amin","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2006.068882_bib83","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/art.10518","article-title":"The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide.","volume":"46","author":"Boileau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.068882_bib84","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.4049\/jimmunol.160.6.2974","article-title":"Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages.","volume":"160","author":"Naraba","year":"1998","journal-title":"J Immunol"},{"key":"10.1136\/ard.2006.068882_bib85","doi-asserted-by":"crossref","first-page":"11660","DOI":"10.1074\/jbc.274.17.11660","article-title":"Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2.","volume":"274","author":"Brock","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2006.068882_bib86","doi-asserted-by":"crossref","first-page":"7220","DOI":"10.1073\/pnas.96.13.7220","article-title":"Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target.","volume":"96","author":"Jakobsson","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2006.068882_bib87","doi-asserted-by":"crossref","first-page":"32783","DOI":"10.1074\/jbc.M003505200","article-title":"Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2.","volume":"275","author":"Murakami","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2006.068882_bib88","doi-asserted-by":"crossref","first-page":"32775","DOI":"10.1074\/jbc.M003504200","article-title":"Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis.","volume":"275","author":"Tanioka","year":"2000","journal-title":"J Biol Chem"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672443700X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672443700X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2006.068882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:58:55Z","timestamp":1737341935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672443700X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S000349672443700X"],"URL":"https:\/\/doi.org\/10.1136\/ard.2006.068882","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2006.068882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 2008 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}